Skip to main content
. 2018 Dec 13;10(4):274. doi: 10.3390/pharmaceutics10040274

Figure 3.

Figure 3

Effect of SPC ULV and MLV on the viability of HepG2 (A) and MDA-MB-468 (B) cells. ** p < 0.01 and *** p < 0.001 vs. control (i.e., vehicle-treated cells), denotes a statistically significant reduction of cell viability compared to control (ANOVA + multiple Dunnett’s comparison post-test). A cell viability lower than 70% respect to control was considered as cytotoxic [26].